A2AR/A2BR antagonist 1
A2AR/A2BR antagonist 1 (compound 7ai) has a dual antagonistic effect on A2AR/A2BR, with the IC50 values of 11.2 nM and 6.4 nM for A2AR and A2BR, respectively. A2AR/A2BR antagonist 1 promotes T cell-mediated cancer cell death.
For research use only. We do not sell to patients.
- Formula: C24H17N9
- Molecular Weight:431.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Adenosine Receptor Isoforms
More
Biological Activity
|
A2AR 11.2 nM (IC50) |
A2BR 6.4 nM (IC50) |
A2AR/A2BR antagonist 1 (compound 7ai) (0.1, 1, 10 μM, 0-48 h) can reverse NECA (HY-103173)-mediated immunosuppression, profoundly promote the activation and killing ability of OT-I CTL cells, thereby exerting anti-cancer activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human Jurkat T cells
-
Concentration:0.1, 1, 10 μM
-
Incubation Time:0-48 h
-
Result:Almost completely abolished NECA (HY-103173)-induced upregulation of expression of immunosuppressive molecules (PD-1 and TIM-3).
Chemical Information
-
Molecular Weight 431.45
-
Formula C24H17N9
-
SMILES
NC1=NC(C2=CN(N=N2)CC3=CNC4=C3C=C(C=C4)C#N)=CC(C5=CC=CC(C#N)=C5C)=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)